sufentanil has been researched along with Cardiovascular Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbasi, BA; Amaro-Estrada, I; Andreas, NS; Ariga, K; Bedrov, D; Bello, AK; Bouganim, N; Braam, B; Cao, Y; Capasso, R; Caro, AL; Chen, G; Chen, Y; Clark, MK; Cossio-Bayugar, R; Dong, D; Gao, D; Gao, T; Ghimire, A; Gul, F; Hamonic, LN; He, Y; Hill, JP; Hollebeek, LD; Hu, B; Iqbal, J; Jardan, YAB; Jiang, M; Jindal, K; John, B; Khan, I; Khan, M; Klarenbach, S; Kumar, V; Li, J; Li, L; Li, Z; Lin, H; Liu, C; Liu, HF; Liu, J; Liu, L; Liu, Z; Ma, R; Mach, T; Mahmood, T; Marath, U; Mathew, D; Mei, C; Muneer, S; Nakamura, J; Ni, H; Okpechi, IG; Padwal, R; Qi, A; Qin, Y; Renjitha, M; Ringrose, J; Scott-Douglas, N; Shahbaz, A; Shi, L; Shojai, S; Singh, SK; Slabu, D; Song, Y; Srivastava, RK; Sultana, N; Takeyasu, K; Tang, SS; Thompson, S; Tinwala, MM; Trinh, E; Valappil, SP; Wang, L; Wang, T; Wang, Y; Wu, W; Xi, H; Yang, M; Yang, Y; Ye, F; Yin, G; Yin, M; Yin, X; Yuan, XS; Zaidi, D; Zeng, L; Zhang, L; Zhang, Z; Zhang, ZC; Zheng, D | 1 |
| Chen, J; Gu, E; Zhang, L; Zhang, Y; Zhao, X; Zhu, B | 1 |
| Lundeberg, S; Roelofse, JA | 1 |
| Hilfiker, O; Larsen, R; Radke, J; Schenk, HD; Sonntag, H | 1 |
| Davis, DP; de Bruijn, NP; Greeley, WJ | 1 |
2 trial(s) available for sufentanil and Cardiovascular Diseases
| Article | Year |
|---|---|
Topics: Aged; Algorithms; Anesthesia, General; Artificial Intelligence; Autophagy; Beclin-1; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cough; Cross Infection; Delirium; Diffusion Magnetic Resonance Imaging; Glucose; Hematocrit; Hemoglobins; Histone Deacetylase 1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; I-kappa B Proteins; Lung Neoplasms; Mitogen-Activated Protein Kinase Kinases; Neoplasms; NF-kappa B; NF-KappaB Inhibitor alpha; Oxycodone; Patient Comfort; Physical Examination; Prognosis; Prospective Studies; Quality of Life; Retrospective Studies; RNA, Messenger; Signal Transduction; Skin Neoplasms; Stroke Volume; Sufentanil; Survival Rate; Ventricular Function, Left; Vomiting | 2022 |
[Haemodynamics, coronary blood flow and myocardial metabolism in man: effects of sufentanil and fentanyl (author's transl)].
Topics: Adult; Blood Glucose; Cardiovascular Diseases; Coronary Circulation; Fatty Acids, Nonesterified; Fentanyl; Hemodynamics; Humans; Lactates; Middle Aged; Myocardium; Oxygen; Pyruvates; Sufentanil | 1980 |
3 other study(ies) available for sufentanil and Cardiovascular Diseases
| Article | Year |
|---|---|
Long-term insulin treatment restores cardioprotection induced by sufentanil postconditioning in diabetic rat heart.
Topics: Animals; Cardiotonic Agents; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Disease Models, Animal; Hypoglycemic Agents; Insulin; Ischemic Postconditioning; Male; Myocardial Reperfusion Injury; Rats, Sprague-Dawley; Sufentanil; Treatment Outcome | 2016 |
Aspects of pharmacokinetics and pharmacodynamics of sufentanil in pediatric practice.
Topics: Administration, Intranasal; Aging; Analgesics, Opioid; Anesthesia, Epidural; Anesthesia, Intravenous; Blood Proteins; Cardiovascular Diseases; Child; Child, Preschool; Cytochrome P-450 CYP3A; Half-Life; Hemodynamics; Humans; Infant; Injections, Spinal; Kidney Failure, Chronic; Protein Binding; Reference Values; Sufentanil | 2011 |
Sufentanil pharmacokinetics in pediatric cardiovascular patients.
Topics: Adolescent; Age Factors; Anesthetics; Cardiovascular Diseases; Child; Child, Preschool; Fentanyl; Half-Life; Humans; Infant; Infant, Newborn; Sufentanil | 1987 |